COMMUNIQUÉS West-GlobeNewswire

Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
17/06/2026
Company expects to report topline 12-month clinical results in the second half of 2027 BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) (Avalyn or the Company), a clinical-stage [...]
Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform
17/06/2026
Raanana, Israel, June 17, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212
17/06/2026
InvestorsTape.com Closely Watching NTHI Ahead of Multiple Clinical, Regulatory, and Data Catalysts DALLAS, June 17, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is rapidly emerging as a [...]
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
17/06/2026
– On track to also complete enrollment in the Seabreeze STAT COPD study this month – – Expect to report topline data from Seabreeze STAT Asthma study in early September 2026 – – Strong balance sheet with cash runway [...]
Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study
17/06/2026
Lead Cell Therapy Demonstrated Complete Tumor Clearance and 100% Long-Term Survival in Preclinical Ovarian Cancer Models; Multiple Regulatory, Manufacturing and Clinical Catalysts Expected Through 2027 CAMBRIDGE, Mass [...]
Precision Neuroscience™ Wins 2026 Webby Award; Earns Back-to-Back Fast Company World Changing Ideas Honor
17/06/2026
Both recognitions cite the Layer 7 cortical interface and its potential to restore independence for people living with paralysis NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision [...]
Merakris Therapeutics Awarded U.S. Department of Veterans Affairs Federal Supply Schedule Contract, Expanding Federal Market Access for Dermacyte® AC Matrix Amniotic Membrane Allograft
17/06/2026
Five-Year Contract Creates New Opportunities for Distribution Partners Serving VA and Federal Healthcare Facilities RESEARCH TRIANGLE PARK, N.C., June 17, 2026 (GLOBE NEWSWIRE) -- Merakris Therapeutics, Inc., a [...]
electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference
17/06/2026
ROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will participate in the iAccess Alpha Virtual [...]
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
17/06/2026
CHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that, through its wholly [...]
Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
17/06/2026
Per May 2026 Type C meeting, AXPAXLI NDA for wet AMD to be based on SOL-1 Week 52 efficacy and safety plus interim SOL-R safety data Ocular to conduct interim SOL-R safety analysis in 4Q 2026 to reach >300 patients [...]
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs
17/06/2026
Company to present at Planet Microcap Conference in Las Vegas between June 16-18 MELBOURNE, Australia, June 17, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) ("Gelteq" or the "Company"), a biotechnology company [...]
Zelluna ASA: Contemplated Private Placement and Retail Offering to Strengthen its Position Ahead of Initial Clinical Data
17/06/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
17/06/2026
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 17 June 2026 at 16.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
TOMI Advances Toward NSF Certification to Address Multi-Billion-Dollar Pharmaceutical, Biotech and Cleanroom Decontamination Markets
17/06/2026
Certification process could position SteraMist® as a validated decontamination standard across biosafety cabinets, containment enclosures, cleanrooms, and life sciences facilities worldwide FREDERICK, Md., June 17, 2026 [...]
CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment
17/06/2026
A data-driven repricing solution that optimizes cost management and complements existing bill review workflows FORT WORTH, Texas, June 17, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (Nasdaq: CRVL), a national provider [...]
Trading in GN Store Nord shares by board members, executives and associated persons
17/06/2026
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
17/06/2026
- Up to $125 million in additional borrowing capacity provides further strategic flexibility - - $50 million of additional capacity funded at amendment closing - WALTHAM, Mass., June 17, 2026 (GLOBE NEWSWIRE) -- Dyne [...]
Trevi Therapeutics Announces Upcoming June and July Event Schedule
17/06/2026
NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
17/06/2026
~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter of 2026 ~ LEXINGTON [...]

Pages